NASDAQ: BGNE       Beigene Ltd Ads
Last Price Today's Change   Day's Range   Trading Volume
330.965   -1.035 (0.31%)  325.52 - 332.83  33,122


Avg Volume (4 weeks):125,426
4 Weeks Range:320.75 - 368.45
4 Weeks Price Volatility (%):
52 Weeks Range:172.51 - 388.97
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

BeiGene Ltd is a United States based clinical-stage biopharmaceutical company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3008  3877  538  3504 

Top 10 Active Counters
 TRCH 5.669+0.599 
 APRE 5.758+0.908 
 SNDL 0.969-0.031 
 AMC 53.63-5.41 
 ORPH 19.38+9.33 
 WISH 10.628-0.642 
 ALF 7.25+0.28 
 TCF 45.180.00 
 AAPL 130.346+0.706 
 F 14.975-0.025 


1. Wall Street Breakfast: Watch 'Em Dots Wall Street Breakfast
2. Daily Futures Trading Strategy 16 June 2021 Where Futures Lies
3. Stocks Down Ahead of FOMC State of The Markets
4. CryptoNews of the Week CryptoNews
5. Taper Talks Buoyed Dollar State of The Markets